Fundamental Valuation Report Baker Hughes(BKR:NYS) Energy:Oil & Gas Equipment & Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$20.10 (USD) 04/16/2021 Weighted Valuation$19.65 (USD) Overall RatingFairly valued to …
Baker Hughes (BKR:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report BlackLine(BL:NAS) Technology:Software – Infrastructure This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$119.09 (USD) 04/16/2021 Weighted Valuation$115.54 (USD) Overall RatingFairly valued to slightly Overvalued by 3.0% Valuation Models …
BlackLine (BL:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report BlackRock(BLK:NYS) Financial Services:Asset Management This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$811.45 (USD) 04/16/2021 Weighted Valuation$776.26 (USD) Overall RatingFairly valued to slightly Overvalued by 4.3% Valuation Models …
BlackRock (BLK:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report BELLUS Health(BLU:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.58 (USD) 04/16/2021 Weighted Valuation$4.32 (USD) Overall RatingOvervalued by 5.7% Valuation Models Adjusted Book Value: $4.12 (USD) …
BELLUS Health (BLU:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report BELLUS Health(BLU:TSE) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$4.57 (USD) / $5.72 (CAD) 04/16/2021 Weighted Valuation$4.58 (USD) / $5.73 (CAD) Use a conversion …
BELLUS Health (BLU:TSE) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Boralex(BLX:TSE) Utilities:Utilities – Renewable This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$43.56 (CAD) 04/16/2021 Weighted Valuation$44.16 (CAD) Overall RatingFairly valued to slightly Undervalued by 1.4% Valuation Models …
Boralex (BLX:TSE) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report BP Midstream Partners(BPMP:NYS) Energy:Oil & Gas Midstream This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$12.79 (USD) 04/16/2021 Weighted Valuation$13.47 (USD) Overall RatingUndervalued by 5.3% Valuation Models …
BP Midstream Partners (BPMP:NYS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Albireo Pharma(ALBO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$32.92 (USD) 04/15/2021 Weighted Valuation$31.89 (USD) Overall RatingFairly valued to slightly Overvalued by 3.1% Valuation Models Adjusted …
Albireo Pharma (ALBO:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Alector(ALEC:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$18.48 (USD) 04/15/2021 Weighted Valuation$18.21 (USD) Overall RatingFairly valued to slightly Overvalued by 1.5% Valuation Models Comparables: $14.55 (USD) …
Alector (ALEC:NAS) Fundamental Valuation Report Read more »
Read More
Fundamental Valuation Report Allogene Therapeutics(ALLO:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$32.86 (USD) 04/15/2021 Weighted Valuation$36.86 (USD) Overall RatingUndervalued by 12.2% Valuation Models Adjusted Book Value: $36.87 (USD) …
Allogene Therapeutics (ALLO:NAS) Fundamental Valuation Report Read more »
Read More